Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-007275
Filing Date
2017-07-07
Accepted
2017-07-07 16:53:30
Documents
50
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0317_immudyneinc.htm 10-Q 449359
2 CERTIFICATION f10q0317ex31i_immudyneinc.htm EX-31.1 17406
3 CERTIFICATIONS f10q0317ex32i_immudyneinc.htm EX-32.1 2967
  Complete submission text file 0001213900-17-007275.txt   3548122

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE immd-20170331.xml EX-101.INS 571507
5 XBRL SCHEMA FILE immd-20170331.xsd EX-101.SCH 36872
6 XBRL CALCULATION FILE immd-20170331_cal.xml EX-101.CAL 27430
7 XBRL DEFINITION FILE immd-20170331_def.xml EX-101.DEF 196755
8 XBRL LABEL FILE immd-20170331_lab.xml EX-101.LAB 393700
9 XBRL PRESENTATION FILE immd-20170331_pre.xml EX-101.PRE 285819
Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-184487 | Film No.: 17955701
SIC: 2833 Medicinal Chemicals & Botanical Products